Gilead Sciences Pharmaceuticals shares jumped 16% after the market closed, the day before yesterday, following a media report that provided encouraging partial data from experiments with the American company's experimental drug "Remdisever" on patients with severe cases of the emerging coronavirus. The (Stat) medical news website reported that a University of Chicago hospital is participating in a study of antivirals, and said it was monitoring a rapid recovery from symptoms of fever and respiratory system, with almost all patients leaving the hospital in less than a week. In the same context, the German "Paul Ehrlich" Institute for Vaccines and Biomedicines expects to soon begin clinical tests for one of the candidate vaccines for combating the virus in Germany. Yesterday, the head of the institute, Klaus Seekotech, said in Berlin that he was sure that there would be tests for other vaccines this year in Germany.
Corona patients respond to a test drug
2020-04-18T07:04:10.054Z
Gilead Sciences Pharmaceuticals shares jumped 16% after the market closed, the day before yesterday, following a media report that provided encouraging partial data from experiments with the American company's experimental drug "Remdisever" on patients with severe cases of the emerging coronavirus. The (Stat) medical news website mentioned a
Source: emara
Similar news:
- They recovered quickly and were discharged from hospitals ... Corona's patients respond to an experimental drug from Gilead 4 years
- Lääkärilehti: Six Finnish hospitals take part in a new coronary drug test - the first patients to receive the medicine next week 4 years
- They all died to their deaths: a 14-year-old futsal junior, a 26-year-old hero doctor, a 42-year-old mother of a large family - 100 stopping fates around the world 4 years
- IS Giant Survey: Corona Time Measures the Strength of a Relationship - “This is a bit like being in a submarine” 4 years